Study of the Influence of Plasma Exchange on the Pharmacokinetics of Rituximab
NCT00820469
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Renal Transplant
Autoimmune Diseases
Interventions
DRUG:
Rituximab 375
DRUG:
rituximab 1000
Sponsor
University Hospital, Toulouse